Status:

COMPLETED

PET MRI as a Staging Tool for Head and Neck Cancer

Lead Sponsor:

Hoag Memorial Hospital Presbyterian

Conditions:

Head Cancer

Neck Cancer

Eligibility:

All Genders

18+ years

Brief Summary

To explore the use of PET/MRI in the staging and pretreatment evaluation of patients with head and neck cancer and to compare this modality to standard PET/CT imaging.

Detailed Description

This study is a prospective clinical study whereby an emerging technology, PET/MRI will be compared to a more standard imaging modality, PET/CT, using newly diagnosed head and neck cancer patients as ...

Eligibility Criteria

Inclusion

  • Active head and neck cancer that require PET/CT regardless of the point of treatment
  • TNM staging I or II

Exclusion

  • Patients whose primary treatment option is chemotherapy or radiation therapy (not surgical)
  • Implanted pacemakers
  • Intracranial aneurysm clips
  • Cochlear implants
  • Certain prosthetic devices
  • Implanted drug infusion pumps
  • Neurostimulators
  • Bone-growth stimulators
  • Certain intrauterine contraceptive devices; or
  • Any other type of iron-based metal implants.
  • MRI should not also be used on persons with the presence of internal metallic objects such as bullets or shrapnel, as well as surgical clips, pins, plates, screws, metal sutures, or wire mesh.
  • Subject with breast tissue expanders.

Key Trial Info

Start Date :

March 3 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 16 2024

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT04750434

Start Date

March 3 2020

End Date

August 16 2024

Last Update

October 15 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hoag Memorial Hospital Presbyterian

Newport Beach, California, United States, 92663